Artificial Intelligence

Aeromag's new GestOp AI promises to cut costs, reduce chemical use, and slash delays, marking a major leap in aviation ground operations efficiency.

A landmark conference merges top organizations to accelerate research on retinal diseases, from gene editing to AI, offering new hope for millions worldwide.

A new class of ultra-flexible graphene brain implants has safely decoded neural signals in a first-in-human study, heralding a new era for surgery.

A 35-year veteran who built a billion-dollar dental health empire is betting on AI to fix the industry's broken administrative backbone. Here's why.

Lone Star Analysis's new patent for multi-agent AI promises explainable, auditable decisions for defense, healthcare, and other critical sectors.

Former Naval Aviator Tricia Shaw brings a 'mission-first' mindset from Morgan Stanley to AXOM Partners, fueling the boutique firm's rapid rise in AI M&A.

The new AI-powered studio from Makko.ai exits beta, promising to turn anyone's game ideas into cohesive 2D assets and playable prototypes.

As AI projects falter on bad data, companies learn that automation without human oversight is a risky bet, especially in regulated industries.

Arelion is bolstering its Danish network to meet surging AI demands, transforming the nation into a critical digital gateway for Northern Europe's tech boom.

Karsan's autonomous e-ATAK has completed commercial service in a ski resort, proving its mettle against snow, ice, and skiers in a major leap for AI.

As ad fraud costs soar, MobileFuse's fifth straight TAG Platinum award signals a deep commitment to transparency, setting a high bar for the industry.

New Cufflink Nova™ AI promises to slash utility bills for schools and hospitals by turning data into decisions, with a core focus on data privacy.

Notable Capital's inaugural 'Prosumer AI 40' list spotlights the tools giving individuals the power of entire teams, defining a new era of work.

Ionic Digital's Bitcoin output fell in March, but a debt-free strategy and a major AI deal suggest a calculated shift toward long-term stability.

The company launched its NeuCool IR150, a plug-and-play liquid cooling rack aimed at making sustainable AI infrastructure more efficient and accessible.

New preclinical data reveals a T cell engager targeting multiple cancer markers at once, a novel strategy to overcome immunotherapy's limits in solid tumors.

A new regenerative development in Missouri plans to power the AI era by creating a self-sufficient ecosystem for energy, water, and compute.

Astellas and Pfizer's PADCEV-Keytruda combo, showing a 47% drop in recurrence risk, earns FDA Priority Review, offering new hope for bladder cancer patients.

VoIP giant Zadarma launches a fully Italian platform, including an AI voice agent, aiming to capture a key European market with deep localization.

Biogen consolidates worldwide rights for its promising immunology drug felzartamab, acquiring China rights from TJ Biopharma in a strategic $850M deal.